Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 131
Filter
1.
Adv Exp Med Biol ; 1321: 183-197, 2021.
Article in English | MEDLINE | ID: mdl-33656724

ABSTRACT

We conducted a retrospective analysis on data of all adults tested for SARS-CoV-2 across our laboratory network in South Africa over a 4-month period. Out of 842,197 tests, 11.7% were positive and 88.3% negative. The prevalence of HIV was 6.25 and 6.31% in the SARS-CoV-2-positive and SARS-CoV-2-negative cohort, respectively (p = 0.444). However, the prevalence of HIV-positive individuals in the critical cohort (9.15%) was higher than in the noncritical group (6.24%) (p = 0.011). Active tuberculosis infection was approximately 50% less in SARS-CoV-2-positive than in SARS-CoV-2-negative individuals. The prevalence of uncontrolled diabetes was 3.4 times higher in SARS-CoV-2-positive cases but was not higher in the critical vs. noncritical cases (p = 0.612). The neutrophil-to-lymphocyte ratio, coagulation markers, urea, and cardiac- and liver-related analytes were significantly elevated in the critical compared to noncritical cases. Platelet count and creatinine concentration did not differ significantly between the two groups. These findings do not support increased prevalence of HIV or tuberculosis in individuals with SARS-CoV-2 infection but do suggest an association of increased disease severity with HIV-positive status. Uncontrolled diabetes was positively associated with a significantly higher prevalence of SARS-CoV-2, and our investigation into analyte changes associated with SARS-CoV-2 disease severity supported previous findings of raised inflammatory markers, coagulation markers, liver- and cardiac-related analytes, and urea but not for creatinine and platelet count.


Subject(s)
COVID-19 , HIV Infections , Adult , Glycated Hemoglobin , HIV Infections/epidemiology , Humans , Laboratories , Retrospective Studies , SARS-CoV-2 , South Africa/epidemiology
2.
Transbound Emerg Dis ; 65(3): 660-675, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29392870

ABSTRACT

Swine enteric coronaviruses, including porcine epidemic diarrhoea virus (PEDV) and porcine deltacoronavirus (PDCoV), have emerged and spread throughout the North American swine industry over the last four years. These diseases cause significant losses within the pork industry and within the first year after PEDV introduction, approximately 10% of the US herd died due to the disease. Similar to other enteric coronaviruses, such as transmissible gastroenteritis virus (TGEV), these emerging swine enteric coronavirus diseases (SECD) are age-dependent, with high morbidity and mortality in neonatal pigs. Since the introduction of SECD, research has focused on investigating viral pathogenesis through experimental inoculation, increasing maternal antibody for neonatal protection, understanding transmission risks through feed and transportation, and outlining the importance of biosecurity in preventing SECD introduction and spread. A survey of swine professionals conducted for this review revealed that the majority of respondents (75%) believe SECD can be eradicated and that most herds have been successful at long-term elimination of SECD after exposure (80%). However, unique properties of SECD, such as ineffective immunity through parenteral vaccination and a low oral infectious dose, play a major role in management of SECD. This review serves to describe the current knowledge of SECD and the characteristics of these viruses which provide both opportunities and challenges for long-term disease control and potential eradication from the US swine population.


Subject(s)
Coronavirus Infections/epidemiology , Coronavirus , Porcine epidemic diarrhea virus , Swine Diseases/epidemiology , Swine Diseases/virology , Animals , Canada/epidemiology , Coronavirus Infections/veterinary , Swine , United States/epidemiology
3.
Biomed Res Int ; 2014: 416727, 2014.
Article in English | MEDLINE | ID: mdl-24719862

ABSTRACT

Porcine reproductive and respiratory syndrome (PRRS) is a high-consequence animal disease with current vaccines providing limited protection from infection due to the high degree of genetic variation of field PRRS virus. Therefore, understanding host immune responses elicited by different PRRSV strains will facilitate the development of more effective vaccines. Using IngelVac modified live PRRSV vaccine (MLV), its parental strain VR-2332, and the heterologous KS-06-72109 strain (a Kansas isolate of PRRSV), we compared immune responses induced by vaccination and/or PRRSV infection. Our results showed that MLV can provide complete protection from homologous virus (VR-2332) and partial protection from heterologous (KS-06) challenge. The protection was associated with the levels of PRRSV neutralizing antibodies at the time of challenge, with vaccinated pigs having higher titers to VR-2332 compared to KS-06 strain. Challenge strain did not alter the cytokine expression profiles in the serum of vaccinated pigs or subpopulations of T cells. However, higher frequencies of IFN-γ-secreting PBMCs were generated from pigs challenged with heterologous PRRSV in a recall response when PBMCs were re-stimulated with PRRSV. Thus, this study indicates that serum neutralizing antibody titers are associated with PRRSV vaccination-induced protection against homologous and heterologous challenge.


Subject(s)
Immunity, Innate , Porcine Reproductive and Respiratory Syndrome/immunology , Porcine respiratory and reproductive syndrome virus/immunology , Vaccination , Animals , Antibodies, Viral/immunology , Interferon-gamma/immunology , Leukocytes, Mononuclear/immunology , Porcine Reproductive and Respiratory Syndrome/prevention & control , Porcine respiratory and reproductive syndrome virus/pathogenicity , Swine , T-Lymphocytes/immunology , Vaccines, Attenuated/administration & dosage , Vaccines, Attenuated/immunology
4.
Curr Top Microbiol Immunol ; 338: 45-55, 2010.
Article in English | MEDLINE | ID: mdl-19802577

ABSTRACT

The mechanisms of dengue virus (DENV) pathogenesis are little understood because we have no models of disease; only humans develop symptoms (dengue fever, DF, or dengue hemorrhagic fever, DHF) and research has been limited to studies involving patients. DENV is very diverse: there are four antigenic groups (serotypes) and three to five genetic groups (genotypes) within each serotype. Thus, it has been difficult to evaluate the relative virulence or transmissibility of each DENV genotype; both of these factors are important determinants of epidemiology and their measurement is complex because the natural cycle of this disease involves human-mosquito-human transmission. Although epidemiological and evolutionary studies have pointed to viral factors in determining disease outcome, only recently developed models could prove the importance of specific viral genotypes in causing severe epidemics and their potential to spread to other continents. These new models involve infection of primary human cell cultures, "humanized" mice and field-collected mosquitoes; also, new mathematical models can estimate the impact of viral replication, human immunity and mosquito transmission on epidemic behavior. DENV evolution does not seem to be rapid and the transmission and dispersal of stable, replication-fit genotypes has been more important in the causation of more severe epidemics. Controversy regarding viral determinants of DENV pathogenesis and epidemiology will continue until virulence and transmissibility can be measured under various conditions.


Subject(s)
Dengue Virus/immunology , Dengue Virus/pathogenicity , Dengue/transmission , Dengue/virology , Models, Immunological , Animals , Dengue Virus/genetics , Disease Models, Animal , Evolution, Molecular , Host-Pathogen Interactions , Humans , Insect Vectors/physiology , Insect Vectors/virology , Mice
5.
Biochem Pharmacol ; 78(7): 803-12, 2009 Oct 01.
Article in English | MEDLINE | ID: mdl-19482012

ABSTRACT

A growing body of evidence suggests that the alpha7 neuronal nicotinic receptor (NNR) subtype is an important target for the development of novel therapies to treat schizophrenia, offering the possibility to address not only the positive but also the cognitive and negative symptoms associated with the disease. In order to probe the relationship of alpha7 function to relevant behavioral correlates we employed TC-5619, a novel selective agonist for the alpha7 NNR subtype. TC-5619 binds with very high affinity to the alpha7 subtype and is a potent full agonist. TC-5619 has little or no activity at other nicotinic receptors, including the alpha4beta2, ganglionic (alpha3beta4) and muscle subtypes. The transgenic th(tk-)/th(tk-) mouse model that reflects many of the developmental, anatomical, and multi-transmitter biochemical aspects of schizophrenia was used to assess the antipsychotic effects of TC-5619. In these mice TC-5619 acted both alone and synergistically with the antipsychotic clozapine to correct impaired pre-pulse inhibition (PPI) and social behavior which model positive and negative symptoms, respectively. Antipsychotic and cognitive effects of TC-5619 were also assessed in rats. Similar to the results in the transgenic mice, TC-5619 significantly reversed apomorphine-induced PPI deficits. In a novel object recognition paradigm in rats TC-5619 demonstrated long-lasting enhancement of memory over a wide dose range. These results suggest that alpha7-selective agonists such as TC-5619, either alone or in combination with antipsychotics, could offer a new approach to treating the constellation of symptoms associated with schizophrenia, including cognitive dysfunction.


Subject(s)
Behavior, Animal/drug effects , Benzofurans/therapeutic use , Cognition Disorders/drug therapy , Neurons/metabolism , Nicotinic Agonists/therapeutic use , Quinuclidines/therapeutic use , Receptors, Nicotinic/physiology , Schizophrenia/drug therapy , Schizophrenic Psychology , Animals , Antipsychotic Agents/pharmacology , Antipsychotic Agents/therapeutic use , Benzofurans/pharmacology , Clozapine/pharmacology , Clozapine/therapeutic use , Cognition Disorders/metabolism , Cognition Disorders/psychology , Exploratory Behavior/drug effects , Female , Male , Maze Learning/drug effects , Mice , Mice, Transgenic , Nicotinic Agonists/pharmacology , Promoter Regions, Genetic , Quinuclidines/pharmacology , Rats , Rats, Sprague-Dawley , Receptor, Fibroblast Growth Factor, Type 1/biosynthesis , Receptor, Fibroblast Growth Factor, Type 1/genetics , Reflex, Startle/drug effects , Schizophrenia/metabolism , Social Behavior , Tyrosine 3-Monooxygenase/genetics , alpha7 Nicotinic Acetylcholine Receptor
6.
J Viral Hepat ; 16(10): 743-8, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19486277

ABSTRACT

Prevalence data concerning viral hepatitis and human immunodeficiency virus (HIV) in the general population are usually scarce. We aimed for a large cohort representative of the general population that required little funding. Autologous blood donors are relatively representative of the general population, and are tested for viral hepatitis and HIV in many countries. However, frequently these data are not captured for epidemiologic purposes. We analysed data from well over 35,000 autologous blood donors as recorded in 21 different transfusion centres for anti-hepatitis C virus (HCV), HBsAg and anti-HIV, as well as TPHA if available. We found a lower prevalence of hepatitis B virus and HCV in East vs West Germany, 0.2%vs 0.32% and 0.16%vs 0.32% respectively, which confirms earlier data in smaller cohorts, thus supporting the value of our approach. HIV was too rare to disclose significant differences, 0.01%vs 0.02%. TPHA was higher in East (0.34%) vs West Germany (0.29%) without significant differences. HCV was more frequent in women vs men. Transfusion institutes managing autologous blood donations should be used as a resource for epidemiological data relating to viral hepatitis and HIV, if such testing is performed routinely. This approach generates data relating to the general population with special emphasis on undiagnosed cases.


Subject(s)
Health Resources , Hepatitis, Viral, Human/epidemiology , Blood Transfusion, Autologous , Female , Germany, East/epidemiology , Germany, West/epidemiology , HIV , HIV Antibodies/blood , HIV Infections/epidemiology , HIV Infections/virology , Hepacivirus , Hepatitis B Surface Antigens/blood , Hepatitis B virus , Hepatitis, Viral, Human/virology , Humans , Male , Mass Screening , Prevalence
7.
Transbound Emerg Dis ; 56(1-2): 1-8, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18771459

ABSTRACT

The objectives of this experiment were to determine how long porcine reproductive and respiratory syndrome virus (PRRSV) could be detected in muscle tissues of experimentally infected pigs and to evaluate the transmissibility of PRRSV to pigs via ingestion of quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR)-positive muscle tissues. Serum, lymphoid tissues, and muscle (M. longissimus dorsi) samples were collected from 135 pigs (89 PRRSV-inoculated pigs and 46 negative control). Between 28 and 202 days post-inoculation, 13 of 89 (14.6%) muscle samples were positive by qRT-PCR. Among these 13, PRRSV was isolated from four of the 13 corresponding serum samples and three of 13 lymphoid tissue samples. In addition, infectious virus was detected in lymphoid tissue homogenates of six of 13 pigs by intramuscular bioassay. Swine transmissibility studies were performed by feeding thirteen 3-week-old PRRSV-naive pigs (recipient pigs) qRT-PCR-positive muscle and then monitoring recipients for evidence of PRRSV viremia by qRT-PCR. No transmission of PRRSV to recipient pigs via consumption of muscle samples was observed. These data suggested that qRT-PCR detected non-infectious PRRSV in pig meat and/or PRRSV is not highly transmissible to susceptible pigs via consumption of PRRSV-contaminated meat.


Subject(s)
Food Contamination/analysis , Meat/virology , Porcine Reproductive and Respiratory Syndrome/transmission , Porcine respiratory and reproductive syndrome virus/isolation & purification , Risk Assessment , Zoonoses , Animals , Consumer Product Safety , Humans , Porcine Reproductive and Respiratory Syndrome/epidemiology , Reverse Transcriptase Polymerase Chain Reaction , Swine
8.
Anal Bioanal Chem ; 375(7): 856-63, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12707751

ABSTRACT

The current level of development of the spectra analysis software Unifit for Windows is presented and evaluated by checking with test spectra. The program is characterized and the correctness of the numerical routines is demonstrated for the particular cases of the Shirley type background model and the Gaussian-Lorentzian product model functions. Different approaches to an optimum fit result are suggested. A convenient analysis of the assessment of the peak fit procedure is proposed. All results are presented in tabular form too, to make the data more comprehensible.

9.
Ophthalmic Plast Reconstr Surg ; 17(2): 120-2, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11281584

ABSTRACT

PURPOSE: Although several reports of supernumerary orbital muscles related to the levator palpebrae superioris have been published, no case has been associated with congenital eyelid retraction. This report describes an apparent causal relationship between an accessory levator muscle slip and congenital eyelid retraction. METHODS: Case report and literature review. RESULTS: Release of the anomalous muscle's attachment from the superior tarsal border alone resulted in resolution of the eyelid retraction. CONCLUSIONS: Eyelid muscle anomalies may be a cause of congenital eyelid retraction. Ophthalmologists who treat eyelid disorders should be aware of this possibility when evaluating and operating on patients with congenital eyelid retraction.


Subject(s)
Eye Abnormalities/complications , Eyelid Diseases/congenital , Eyelid Diseases/etiology , Oculomotor Muscles/abnormalities , Orbit , Child, Preschool , Eye Abnormalities/surgery , Eyelid Diseases/surgery , Humans , Male , Oculomotor Muscles/surgery , Orbit/pathology
10.
Vector Borne Zoonotic Dis ; 1(2): 159-68, 2001.
Article in English | MEDLINE | ID: mdl-12680353

ABSTRACT

Outbreaks of dengue hemorrhagic fever have coincided with the introduction of the Southeast (SE) Asian genotype of dengue type 2 virus in the Western Hemisphere. This introduced genotype appears to be rapidly displacing the indigenous, American genotype of dengue 2 virus throughout the region. These field observations raise the possibility that the SE Asian genotype of dengue 2 is better adapted for vector transmission than its American counterpart. To evaluate this hypothesis, we compared the ability of viral strains of the SE Asian and American genotypes to infect, replicate, and disseminate within vector mosquitoes (Aedes aegypti). Viral strains of the SE Asian genotype tended to infect and disseminate more efficiently in mosquitoes than did variants of the American genotype. These differences, however, were observed solely in field-derived mosquitoes, whereas viral infection rates were virtually identical in the laboratory-adapted Rockefeller colony of Ae. aegypti. Our findings could provide a physiological basis for the contrasting patterns of dengue virus genotype transmission and spread. Such an understanding of functional differences between viral strains and genotypes may ultimately improve surveillance and intervention strategies.


Subject(s)
Aedes/physiology , Aedes/virology , Dengue Virus/genetics , Dengue Virus/physiology , Insect Vectors/physiology , Insect Vectors/virology , Americas , Animals , Asia , Base Sequence , Dengue Virus/classification , Genes, Viral/genetics , Genotype , Time Factors
12.
Ophthalmic Plast Reconstr Surg ; 16(1): 39-41, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10674731

ABSTRACT

PURPOSE: Trauma and infection sometimes produce lower lid malpositions that are difficult to repair cosmetically with standard canthoplasty techniques. A new variation is described. METHODS: Surgical techniques of the tarsal strip canthoplasty and of lateral tarsorrhaphy are combined into the tarsal sandwich. RESULTS: Representative cases with preoperative and postoperative photos are presented. CONCLUSION: The sandwich technique allows the surgeon more flexibility in achieving the necessary vertical lift of the lateral canthus in difficult cases of entropion, ectropion, and lagophthalmos.


Subject(s)
Blepharoplasty/methods , Ectropion/surgery , Entropion/surgery , Eyelids/surgery , Adult , Cellulitis/complications , Ectropion/etiology , Entropion/etiology , Facial Injuries/complications , Female , Humans , Male , Orbital Diseases/complications , Suture Techniques
13.
J Virol ; 74(6): 2955-9, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10684318

ABSTRACT

The recent isolation of a nonhuman primate hepadnavirus from woolly monkeys prompted an examination of other primates for potentially new hepadnaviruses. A serological analysis of 30 captive gibbons revealed that 47% were positive for at least one marker of ongoing or previous infection with a hepatitis B virus (HBV). The amino acid sequences of the core and surface genes of human and gibbon virus isolates were very similar. Phylogenetic analysis indicated that the gibbon isolates lie within the human HBV family, indicating that these HBV isolates most likely stem from infection of gibbons from a human source.


Subject(s)
Hepadnaviridae Infections/veterinary , Hylobates/virology , Monkey Diseases/virology , Amino Acid Sequence , Animals , Base Sequence , DNA, Viral , Hepadnaviridae/classification , Hepadnaviridae/genetics , Hepadnaviridae/immunology , Hepadnaviridae Infections/blood , Hepadnaviridae Infections/immunology , Hepadnaviridae Infections/virology , Hepatitis B Antibodies/blood , Hepatitis B Antibodies/immunology , Hepatitis B Core Antigens/blood , Hepatitis B Core Antigens/immunology , Hepatitis B Surface Antigens/blood , Hepatitis B Surface Antigens/genetics , Hepatitis B Surface Antigens/immunology , Hepatitis B virus/classification , Hepatitis B virus/genetics , Hepatitis B virus/isolation & purification , Humans , Molecular Sequence Data , Monkey Diseases/blood , Monkey Diseases/immunology , Phylogeny
14.
Vet Clin North Am Equine Pract ; 16(3): 553-63, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11219349

ABSTRACT

The emergence of epidemic VEE viruses has been reported ever since the virus was first described; this phenomenon is likely to continue to occur because of the high mutation rate of these RNA viruses. A vaccine that was first developed by the US Military for human use has proved helpful in curtailing the spread of VEE virus during epizootics of the disease in equids but not during human epidemics. It has not, however, eliminated the source of these highly pathogenic and transmissible viruses. Occurrences of VEE in equids in Mexico in recent years suggest that the present vaccine is not effective in interrupting transmission of new epizootic viruses arising from what were previously known as avirulent enzootic cycles. Future vaccines against VEE should be based on immunogens derived from enzootic viruses to interrupt VEE virus transmission at the source itself rather than waiting for virulent phenotypes of VEE virus to emerge.


Subject(s)
Encephalitis Virus, Venezuelan Equine/isolation & purification , Encephalomyelitis, Venezuelan Equine/veterinary , Horse Diseases/epidemiology , Animals , Disease Outbreaks/veterinary , Disease Vectors , Encephalitis Virus, Venezuelan Equine/classification , Encephalitis Virus, Venezuelan Equine/genetics , Encephalomyelitis, Venezuelan Equine/epidemiology , Encephalomyelitis, Venezuelan Equine/etiology , Encephalomyelitis, Venezuelan Equine/therapy , Horse Diseases/etiology , Horse Diseases/therapy , Horses , Serotyping
15.
J Virol ; 73(6): 4738-47, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10233934

ABSTRACT

The understanding of dengue virus pathogenesis has been hampered by the lack of in vitro and in vivo models of disease. The study of viral factors involved in the production of severe dengue, dengue hemorrhagic fever (DHF), versus the more common dengue fever (DF), have been limited to indirect clinical and epidemiologic associations. In an effort to identify viral determinants of DHF, we have developed a method for comparing dengue type 2 genomes (reverse transcriptase PCR in six fragments) directly from patient plasma. Samples for comparison were selected from two previously described dengue type 2 genotypes which had been shown to be the cause of DF or DHF. When full genome sequences of 11 dengue viruses were analyzed, several structural differences were seen consistently between those associated with DF only and those with the potential to cause DHF: a total of six encoded amino acid charge differences were seen in the prM, E, NS4b, and NS5 genes, while sequence differences observed within the 5' nontranslated region (NTR) and 3' NTR were predicted to change RNA secondary structures. We hypothesize that the primary determinants of DHF reside in (i) amino acid 390 of the E protein, which purportedly alters virion binding to host cells; (ii) in the downstream loop (nucleotides 68 to 80) of the 5' NTR, which may be involved in translation initiation; and (iii) in the upstream 300 nucleotides of the 3' NTR, which may regulate viral replication via the formation of replicative intermediates. The significance of four amino acid differences in the nonstructural proteins NS4b and NS5, a presumed transport protein and the viral RNA polymerase, respectively, remains unknown. This new approach to the study of dengue virus genome differences should better reflect the true composition of viral RNA populations in the natural host and permit their association with pathogenesis.


Subject(s)
Dengue Virus/genetics , 3' Untranslated Regions/chemistry , 5' Untranslated Regions/chemistry , Amino Acid Sequence , Base Sequence , Dengue Virus/classification , Dengue Virus/pathogenicity , Genotype , Humans , Molecular Sequence Data , Phylogeny , RNA, Viral/chemistry , Viral Envelope Proteins/chemistry , Viral Nonstructural Proteins/chemistry
16.
Artif Organs ; 23(1): 87-97, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9950185

ABSTRACT

Particles with specific ligands for the adsorption of plasma proteins can be used in therapeutic or preparative apheresis. The development of these particles may benefit from an improved knowledge of the relationship between protein adsorption and the structure of ligands. Nanoparticles were functionalized with aliphatic diamines of increasing chain length; with the amino acids lysine, tryptophan, histidine, and their corresponding amines; and with tryptophan and histidine spaced with diamines of different length. Suitable protocols were developed for the washing of particles and the subsequent desorption of proteins adsorbed from human plasma. The adsorption pattern, as well as the quantification of the overall adsorption of proteins on these modified particles, was investigated with gel electrophoresis. This was followed by immunoblotting which yielded specific assessments of bound human serum albumin and fibrinogen. The comparison of protein adsorption with surface charge density and measured hydrophobicities yielded no simple correlations although in general more hydrophobic ligands bound higher quantities of protein. The detection of human serum albumin yielded similar results because it was observed for overall protein adsorption while the adsorption of fibrinogen expressed a different pattern. In this case, particular nanoparticles functionalized with aliphatic diamines bound significantly higher amounts of fibrinogen than all other ligands.


Subject(s)
Blood Component Removal/methods , Blood Proteins/chemistry , Polymethacrylic Acids/chemistry , Polystyrenes/chemistry , Adsorption , Blood Component Removal/instrumentation , Blood Proteins/analysis , Diamines/chemistry , Electrophoresis, Polyacrylamide Gel , Fibrinogen/analysis , Fibrinogen/chemistry , Fluorescent Dyes , Histamine/chemistry , Histidine/chemistry , Humans , Immunoblotting , Ligands , Lysine/chemistry , Molecular Weight , Particle Size , Rose Bengal , Serum Albumin/analysis , Serum Albumin/chemistry , Sodium Dodecyl Sulfate , Surface Properties , Surface-Active Agents , Tryptamines/chemistry , Tryptophan/chemistry , Water/chemistry
17.
Am J Trop Med Hyg ; 59(1): 100-7, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9684636

ABSTRACT

Two outbreaks of encephalitis consistent with an etiology of Venezuelan equine encephalitis (VEE) virus occurred in equines on the Pacific coast of southern Mexico in 1993 (Chiapas State) and in 1996 (Oaxaca State). In Chiapas, there were 125 cases, of which 63 were fatal and in Oaxaca, there were 32 cases and 12 fatalities. Virus was isolated from two horses from each outbreak, including three brain isolates and one from blood. Virus isolates (93-42124, ISET-Chi93, Oax131, and Oax142) were shown by indirect immunofluorescence, hemagglutination inhibition, monoclonal antibody ELISA, and nucleotide sequencing to be VEE virus, subtype IE, a type previously thought to be equine-avirulent. Genetic characterization and phylogenetic analysis indicated that the outbreak viruses were identical or nearly identical to one another and that they were closely related to equine-avirulent IE strains from Guatemala and the Gulf coast of Mexico. In a plaque-reduction neutralization test, sera collected from healthy horses in Chiapas and Oaxaca reacted significantly better with isolate 93-42124 than with Guatemala IE isolate 68U201, suggesting that subtle genetic changes may have resulted in alteration of neutralization domains. It is not clear whether these differences may also influence equine virulence. However, renewed VEE virus subtype IE activity in Mexico, and its apparent conversion to equine virulence, underscores the need for increased surveillance, additional laboratory and epidemiologic studies in VEE-endemic regions, and possibly new vaccines.


Subject(s)
Disease Outbreaks/veterinary , Encephalitis Virus, Venezuelan Equine/classification , Encephalomyelitis, Venezuelan Equine/veterinary , Horse Diseases/virology , Amino Acid Sequence , Animals , Animals, Newborn , Antibodies, Viral/blood , Antigens, Viral/analysis , Encephalitis Virus, Venezuelan Equine/genetics , Encephalitis Virus, Venezuelan Equine/immunology , Encephalomyelitis, Venezuelan Equine/epidemiology , Encephalomyelitis, Venezuelan Equine/virology , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Horse Diseases/epidemiology , Horses , Male , Mexico/epidemiology , Mice , Molecular Sequence Data , Neutralization Tests/veterinary , Phylogeny , Polymerase Chain Reaction/veterinary , Serotyping/veterinary , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/genetics
20.
Proc Natl Acad Sci U S A ; 95(10): 5757-61, 1998 May 12.
Article in English | MEDLINE | ID: mdl-9576957

ABSTRACT

Hepatitis B virus (HBV) infections are a major worldwide health problem with chronic infections leading to cirrhosis and liver cancer. Viruses related to human HBV have been isolated from birds and rodents, but despite efforts to find hepadnaviruses that infect species intermediate in evolution between rodents and humans, none have been described. We recently isolated a hepadnavirus from a woolly monkey (Lagothrix lagotricha) that was suffering from fulminant hepatitis. Phylogenetic analysis of the nucleotide sequences of the core and surface genes indicated that the virus was distinct from the human HBV family, and because it is basal (ancestral) to the human monophyletic group, it probably represents a progenitor of the human viruses. This virus was designated woolly monkey hepatitis B virus (WMHBV). Analysis of woolly monkey colonies at five zoos indicated that WMHBV infections occurred in most of the animals at the Louisville zoo but not at four other zoos in the United States. The host range of WMHBV was examined by inoculation of one chimpanzee and two black-handed spider monkeys (Ateles geoffroyi), the closest nonendangered relative of the woolly monkey. The data suggest that spider monkeys are susceptible to infection with WMHBV and that minimal replication was observed in a chimpanzee. Thus, we have isolated a hepadnavirus with a host intermediate between humans and rodents and establishes a new animal model for evaluation of antiviral therapies for treating HBV chronic infections.


Subject(s)
Cebidae/virology , Disease Models, Animal , Hepadnaviridae/isolation & purification , Hepatitis B/veterinary , Hepatitis B/virology , Animals , DNA, Viral/chemistry , Genotype , Hepadnaviridae/genetics , Humans , Molecular Sequence Data , Pedigree , Phylogeny , Restriction Mapping
SELECTION OF CITATIONS
SEARCH DETAIL
...